XJPX
2413
Market cap7.71bUSD
Jul 10, Last price
1,870.00JPY
1D
-0.27%
1Q
16.95%
Jan 2017
26.99%
IPO
2,201.54%
Name
M3 Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
M3, Inc., a Japanese corporation established in 2000 and headquartered in Tokyo, primarily delivers internet-based services to physicians and other healthcare professionals. Its operations are strategically divided into five key segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. The company manages an extensive portfolio of digital platforms tailored for medical practitioners. This includes m3.com, an exclusive online portal offering healthcare information, and MR-kun, which enables member doctors to continuously access updates and content from the m3com system. QOL-kun further supports members with non-medical, life-enhancement information. For the general public, M3 operates AskDoctors, where registered medical experts address health and illness inquiries. On an international scale, the company provides MDLinx for U.S. medical professionals and Doctorsnetuk in the U.K., which assists pharmaceutical companies and hosts drug information databases across France, Germany, and Spain. Additionally, M3 supports career development for doctors and pharmacists through its m3com CAREER service. Beyond these online platforms, M3, Inc. engages in a wide array of activities within the medical and pharmaceutical sectors. This encompasses sales and marketing initiatives for pharmaceuticals and medical devices, along with the development, distribution, and maintenance of electronic medical records and equipment for healthcare institutions. The company also conducts surveys for medical professionals, offers online sales and marketing support to pharmaceutical firms, provides management consulting and assistance to medical facilities, operates home-visit nursing services, delivers human resources solutions for the healthcare industry, and manages clinical trial facilities. Originally incorporated as So-netM3, Inc., the company officially rebranded to M3, Inc. in January 2010.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||